Original language | English |
---|---|
Title of host publication | International Encyclopedia of the Social & Behavioral Sciences: Second Edition |
Editors | James D Wright |
Place of Publication | London |
Publisher | Elsevier |
Pages | 164-173 |
Number of pages | 10 |
Volume | 18 |
Edition | 2nd edition |
ISBN (Electronic) | 978-0-08-097087-5 |
ISBN (Print) | 9780080970868 |
DOIs | |
Publication status | Published - 26 Mar 2015 |
Abstract
There are often good scientific and ethical reasons for using placebo controls in clinical trials. At the same time placebo use is
controversial, especially when an established effective treatment is being withheld from the control group. This article gives
an overview of the key ethical positions in the controversy around placebo-controlled trials. While some argue that placebo
controls can only be used when withholding or delaying an established effective treatment poses no or negligible risks to
participants, others hold that the risks should be low or acceptable in light of the social value of the knowledge to be gained
from the research. The article also describes different positions on placebo use in trials in low- and middle-income countries
where study participants may not have had access to an established effective treatment outside the trial.
controversial, especially when an established effective treatment is being withheld from the control group. This article gives
an overview of the key ethical positions in the controversy around placebo-controlled trials. While some argue that placebo
controls can only be used when withholding or delaying an established effective treatment poses no or negligible risks to
participants, others hold that the risks should be low or acceptable in light of the social value of the knowledge to be gained
from the research. The article also describes different positions on placebo use in trials in low- and middle-income countries
where study participants may not have had access to an established effective treatment outside the trial.
Keywords
- Clinical equipoise
- Clinical research ethics
- Clinical trial design
- Clinical trials
- Human subjects research
- Investigator obligations
- LMICs (low- and middle-income countries)
- Placebo
- Placebo-controlled trials
- Randomized clinical trials
- Risks
- Therapeutic obligations